This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

Oncothyreon: A Failed Drug Autopsy Performed By A Short Seller

Fund manager Martin Shkreli offers advice on how to avoid the next Oncothyreon blowup.

Nektar Therapeutics Is a Short
Nektar Therapeutics Is a Short

09/12/12 - 07:08 AM EDT

Investor Martin Shkreli believes Nektar's constipation drug is a bust and the stock is a good short.

Page 1 of 1
< Previous
Next >
Top Rated Stocks Top Rated Funds Top Rated ETFs